Page last updated: 2024-12-08

apstatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

apstatin: inhibits aminopeptidase P; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID447280
CHEMBL ID311875
SCHEMBL ID6667113
MeSH IDM0255723

Synonyms (24)

Synonym
CHEMBL311875 ,
(s)-1-[(s)-1-((2s,3r)-3-amino-2-hydroxy-4-phenyl-butyryl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carboxylic acid ((s)-1-carbamoyl-ethyl)-amide
bdbm50078401
DB04092
1N51
apstatin
n-[(2s,3r)-3-amino-2-hydroxy-4-phenyl-butanoyl]-l-prolyl-l-prolyl-l-alaninamide
(2s)-1-[(2s)-1-[(2s,3r)-3-amino-2-hydroxy-4-phenylbutanoyl]pyrrolidine-2-carbonyl]-n-[(2s)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide
n-((2s,3r)-3-amino-2-hydroxy-4-phenylbutanoyl)-l-prolyl-l-prolyl-l-alaninamide
unii-jzk8p9ag86
160470-73-5
jzk8p9ag86 ,
gtpl8803
CCG-207884
SCHEMBL6667113
n-[(2s,3r)-3-amino-2-hydroxy-4-phenylbutanoyl]-l-prolyl-l-prolyl-l-alaninamide
l-alaninamide, 1-((2s,3r)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-l-prolyl-l-prolyl-
DTXSID30936303
1-[1-(3-amino-2-hydroxy-4-phenylbutanoyl)prolyl]-n-(1-hydroxy-1-iminopropan-2-yl)pyrrolidine-2-carboximidic acid
Q27074485
(s)-n-((s)-1-amino-1-oxopropan-2-yl)-1-((s)-1-((2s,3r)-3-amino-2-hydroxy-4-phenylbutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide
aminopeptidase p inhibitor
l-alaninamide, 1-[(2s,3r)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-l-prolyl-l-prolyl-
1-[1-(3-amino-2-hydroxy-4-phenylbutanoyl)pyrrolidine-2-carbonyl]-n-(1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide

Research Excerpts

Actions

ExcerptReferenceRelevance
"Apstatin did not inhibit ACE or other known Bk-degrading enzymes."( Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
Maggiora, LL; Orawski, AT; Prechel, MM; Simmons, WH, 1995
)
1.27

Compound-Compound Interactions

ExcerptReferenceRelevance
" We wished to determine the cardioprotective actions of an aminopeptidase P inhibitor, apstatin alone and in combination with enalapril/lisinopril/ramipril in an in vivo rat model of acute ischemia (30 min) and reperfusion (4 h)."( Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.
Akula, A; Kota, MK; Routhu, KV; Veeravalli, KK, 2003
)
0.83

Bioavailability

ExcerptReferenceRelevance
" These findings indicate decreased bradykinin bioavailability contributes to impaired cerebral arterial dilation in FHH rats."( Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats.
Harder, DR; Hye Khan, MA; Imig, JD; Rarick, KR; Roman, RJ; Sharma, A, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" Pretreatment with 10 mg of quinapril significantly shifted the dose-response curve for bradykinin to the left (effect of quinapril; F = 77."( Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.
Brown, NJ; Kim, KS; Kumar, S; Simmons, WH, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Xaa-Pro aminopeptidaseEscherichia coliKi14.000014.000014.000014.0000AID977610
Xaa-Pro aminopeptidase 2Homo sapiens (human)IC50 (µMol)4.50002.90004.50006.1000AID38385; AID38390
Xaa-Pro dipeptidaseHomo sapiens (human)IC50 (µMol)4.90004.90004.90004.9000AID162622
Cytosol aminopeptidaseHomo sapiens (human)IC50 (µMol)0.30000.30000.30000.3000AID101349
Xaa-Pro aminopeptidase 2Rattus norvegicus (Norway rat)IC50 (µMol)4.10004.10004.10004.1000AID38391
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
proteolysisXaa-Pro aminopeptidase 2Homo sapiens (human)
proteolysisXaa-Pro dipeptidaseHomo sapiens (human)
amino acid metabolic processXaa-Pro dipeptidaseHomo sapiens (human)
collagen catabolic processXaa-Pro dipeptidaseHomo sapiens (human)
negative regulation of programmed cell deathXaa-Pro dipeptidaseHomo sapiens (human)
proteolysisCytosol aminopeptidaseHomo sapiens (human)
proteolysisXaa-Pro aminopeptidase 1Homo sapiens (human)
bradykinin catabolic processXaa-Pro aminopeptidase 1Homo sapiens (human)
negative regulation of programmed cell deathXaa-Pro aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
aminopeptidase activityXaa-Pro aminopeptidase 2Homo sapiens (human)
metal ion bindingXaa-Pro aminopeptidase 2Homo sapiens (human)
metalloaminopeptidase activityXaa-Pro aminopeptidase 2Homo sapiens (human)
metallocarboxypeptidase activityXaa-Pro dipeptidaseHomo sapiens (human)
protein bindingXaa-Pro dipeptidaseHomo sapiens (human)
manganese ion bindingXaa-Pro dipeptidaseHomo sapiens (human)
metalloaminopeptidase activityXaa-Pro dipeptidaseHomo sapiens (human)
proline dipeptidase activityXaa-Pro dipeptidaseHomo sapiens (human)
peptidase activityXaa-Pro dipeptidaseHomo sapiens (human)
aminopeptidase activityCytosol aminopeptidaseHomo sapiens (human)
carboxypeptidase activityCytosol aminopeptidaseHomo sapiens (human)
protein bindingCytosol aminopeptidaseHomo sapiens (human)
metalloexopeptidase activityCytosol aminopeptidaseHomo sapiens (human)
manganese ion bindingCytosol aminopeptidaseHomo sapiens (human)
metalloaminopeptidase activityCytosol aminopeptidaseHomo sapiens (human)
peptidase activityCytosol aminopeptidaseHomo sapiens (human)
aminopeptidase activityXaa-Pro aminopeptidase 1Homo sapiens (human)
manganese ion bindingXaa-Pro aminopeptidase 1Homo sapiens (human)
protein homodimerization activityXaa-Pro aminopeptidase 1Homo sapiens (human)
metalloaminopeptidase activityXaa-Pro aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
extracellular regionXaa-Pro aminopeptidase 2Homo sapiens (human)
plasma membraneXaa-Pro aminopeptidase 2Homo sapiens (human)
membraneXaa-Pro aminopeptidase 2Homo sapiens (human)
extracellular exosomeXaa-Pro aminopeptidase 2Homo sapiens (human)
side of membraneXaa-Pro aminopeptidase 2Homo sapiens (human)
extracellular exosomeXaa-Pro dipeptidaseHomo sapiens (human)
nucleusCytosol aminopeptidaseHomo sapiens (human)
trans-Golgi networkCytosol aminopeptidaseHomo sapiens (human)
focal adhesionCytosol aminopeptidaseHomo sapiens (human)
extracellular exosomeCytosol aminopeptidaseHomo sapiens (human)
cytoplasmCytosol aminopeptidaseHomo sapiens (human)
cytosolXaa-Pro aminopeptidase 1Homo sapiens (human)
cytoplasmXaa-Pro aminopeptidase 1Homo sapiens (human)
cytosolXaa-Pro aminopeptidase 1Homo sapiens (human)
extracellular exosomeXaa-Pro aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID38391Activity against membrane bound rat aminopeptidase P1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID101349Inhibition against Leucyl aminopeptidase from pig kidney.1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID38389Inhibition against cytosolic Aminopeptidase P from human heart.1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID38384Inhibition against Aminopeptidase P from Escherichia coli.1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID162622Inhibition against Prolidase from pig kidney.1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID38385Inhibition against membrane bound monkey aminopeptidase P1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID38388Inhibition against Aminopeptidase P from human platelets.1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID38390Inhibition against membrane bound human aminopeptidase P1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID38386Inhibition against Aminopeptidase P from bovine.1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID1345337Human X-prolyl aminopeptidase 2 (M24: Methionyl aminopeptidase)1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID1345340Human X-prolyl aminopeptidase 1 (M24: Methionyl aminopeptidase)1999Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
AID1811Experimentally measured binding affinity data derived from PDB2004Acta crystallographica. Section D, Biological crystallography, Oct, Volume: 60, Issue:Pt 10
Structure of Escherichia coli aminopeptidase P in complex with the inhibitor apstatin.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2004Acta crystallographica. Section D, Biological crystallography, Oct, Volume: 60, Issue:Pt 10
Structure of Escherichia coli aminopeptidase P in complex with the inhibitor apstatin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (39.13)18.2507
2000's11 (47.83)29.6817
2010's3 (13.04)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.43 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]